Polar Asset Management Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-163,000
| Closed | -$3.71M | – | 770 |
|
|
2024
Q3 | $3.71M | Buy |
163,000
+53,100
| +48% | +$1.21M | 0.08% | 231 |
|
|
2024
Q2 | $1.43M | Sell |
109,900
-1,500
| -1% | -$19.5K | 0.03% | 340 |
|
|
2024
Q1 | $1.95M | Sell |
111,400
-48,300
| -30% | -$846K | 0.03% | 348 |
|
|
2023
Q4 | $3.48M | Buy |
159,700
+83,100
| +108% | +$1.81M | 0.06% | 251 |
|
|
2023
Q3 | $1.18M | Buy |
+76,600
| New | +$1.18M | 0.03% | 419 |
|
|
2023
Q1 | – | Sell |
-204,600
| Closed | -$5.98M | – | 1123 |
|
|
2022
Q4 | $5.98M | Sell |
204,600
-106,200
| -34% | -$3.1M | 0.07% | 344 |
|
|
2022
Q3 | $6.38M | Buy |
310,800
+251,100
| +421% | +$5.15M | 0.08% | 366 |
|
|
2022
Q2 | $691K | Hold |
59,700
| – | – | 0.01% | 733 |
|
|
2022
Q1 | $1.1M | Hold |
59,700
| – | – | 0.01% | 646 |
|
|
2021
Q4 | $1.18M | Hold |
59,700
| – | – | 0.01% | 632 |
|
|
2021
Q3 | $982K | Buy |
+59,700
| New | +$982K | 0.01% | 618 |
|